Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.907,11
1,62%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Theratechnologies Inc (THTX) Theratechnologies Inc (THTX) Notizie

Theratechnologies Inc

THTX
1,28
-0,06 (-4,48%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202413:30GLOBETheratechnologies to Present Long-Term Efficacy, Safety and..
15/4/202422:15GLOBETheratechnologies Announces Mailing of Management Proxy..
11/4/202413:30GLOBETheratechnologies to Present at the 2024 Bloom Burton & Co...
10/4/202413:30GLOBETheratechnologies Reports Financial Results and Provides..
10/4/202413:15IHMARKETNEWSU.S. Index Futures Show Mixed Trend Ahead of Key Inflation..
08/4/202422:30GLOBETheratechnologies Preclinical Data Presentation at AACR 2024..
05/4/202417:00GLOBETheratechnologies Appoints Elina Tea to its Board of..
03/4/202413:30GLOBETheratechnologies to Announce First Quarter 2024 Financial..
28/3/202412:30GLOBETheratechnologies to Present Preclinical Data at AACR on..
22/3/202414:36GLOBETheratechnologies Announces Update on its Preclinical..
22/3/202401:00GLOBETheratechnologies Appoints Jordan Zwick to its Board of..
21/3/202412:30GLOBETheratechnologies Initiates Increased Dose Level in Phase 1..
29/2/202422:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202422:34GLOBETheratechnologies Announces the Resignation of One of Its..
27/2/202414:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/2/202413:30GLOBETheratechnologies Receives Refusal to File Letter for..
21/2/202414:01EDGAR2Form 20-F - Annual and transition report of foreign private..
21/2/202414:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/2/202413:30GLOBETheratechnologies Reports Financial Results for the Fourth..
20/2/202413:30GLOBETheratechnologies Announces Publication in Frontiers in..
15/2/202414:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/2/202413:30GLOBETheratechnologies Completes Enrollment of First Six Patients..
06/2/202420:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/2/202413:30GLOBETheratechnologies to Announce Fourth Quarter and Full Year..
01/2/202417:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202419:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202413:00GLOBETheratechnologies Receives Complete Response Letter (CRL)..
23/1/202420:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202413:30GLOBETheratechnologies Receives Update from FDA on Tesamorelin F8..
04/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/1/202422:28EDGAR2Form F-3/A - Registration statement by foreign private..
02/1/202415:00APSWill This Dual-Listed Bio-Pharma Catch New Year Action?
02/1/202413:30GLOBETheratechnologies Submits sBLA for Trogarzo® Intramuscular..
21/12/202322:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202322:12PRNCATheratechnologies annonce le renouvellement de son..
21/12/202322:09PRNCATheratechnologies Announces Renewal of Shelf Prospectus and..
21/12/202319:21EDGAR2Form F-3 - Registration statement by foreign private issuers
13/12/202320:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202313:30GLOBETheratechnologies Announces FDA Approval of Trogarzo®..
28/11/202322:52EDGAR2Form SC 13D - General statement of acquisition of beneficial..
24/11/202313:30GLOBETheratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation..
06/11/202319:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202318:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202319:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202317:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202317:34GLOBETheratechnologies Announces Closing of US$25 Million Public..
27/10/202303:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202315:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202314:00GLOBETheratechnologies Announces Pricing of US$25 Million Public..
25/10/202322:13GLOBETheratechnologies Announces Proposed Public Offering of..
Apertura: 1,31 Min: 1,27 Max: 1,32
Chiusura: 1,34

La tua Cronologia

NASDAQ
THTX
Theratechnologies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network